CB32KZZ
Positron Emission Tomographic (PET) Imaging Lungs and Bronchi to None with None, Fluorine 18 (F-18) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | B Respiratory System |
| Operation | 3 Positron Emission Tomographic (PET) Imaging |
| Body Part | 2 Lungs and Bronchi |
| Approach | K Fluorine 18 (F-18) |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for three dimensional display of images developed from the simultaneous capture, 180 degrees apart, of radioactive emissions
Procedure Overview
PET imaging of the respiratory system uses a positron-emitting radiotracer, most often fluorodeoxyglucose (FDG), injected into a vein and taken up by tissues in proportion to their metabolic activity. As the tracer decays it emits paired photons in opposite directions, and detectors positioned around the chest capture these coincident pairs to build a three-dimensional picture of metabolic activity throughout the lungs and mediastinum. Tissue that is more metabolically active, which includes many cancers, lights up brighter than surrounding normal tissue.
The leading use of this study is evaluating a lung nodule or mass found on CT to judge how likely it is to be malignant, and staging known lung cancer by checking for spread to lymph nodes or distant sites. It is also used after treatment to see whether a tumor is still metabolically active, which can distinguish residual disease from scar tissue left behind by radiation or surgery.
Anatomy & Axis Detail
Lungs and Bronchi
Positron emission tomography of the lungs and bronchi most commonly uses an intravenously injected glucose analog to identify tissue with elevated metabolic activity, a pattern characteristic of malignancy, active infection, or inflammation, making this the primary imaging tool for staging and characterizing pulmonary nodules and lung cancer. Because the technique measures metabolic uptake rather than structure, it complements CT findings by helping distinguish malignant from benign lesions and by detecting nodal or distant spread that anatomic imaging alone may miss. The lungs' constant respiratory motion and variable tissue density require attenuation correction during reconstruction, and uptake is typically quantified with a standardized value to support comparison across lesions and over time as treatment response is assessed.
Radionuclide: Fluorine 18 (F-18)
Fluorine 18 (F-18) identifies PET studies using this positron-emitting radionuclide, most familiar as the label in fluorodeoxyglucose used for oncologic, cardiac, and neurologic metabolic imaging. Its longer half-life relative to other PET isotopes like Carbon 11 or Oxygen 15 allows it to be produced off-site and transported, making it the most widely used PET tracer isotope captured by this value.
Coding & Documentation
Coding this family requires the report to confirm the imaging method relied on paired, opposed photon detection rather than a rotating single-photon camera, and to name the radiotracer used, since that governs the qualifier character. Many PET studies are performed as a combined PET/CT, and documentation should make clear that the nuclear medicine component itself was completed, not just the CT correlation. A common error is coding a PET/CT solely from the imaging protocol name without confirming in the body of the report that emission data were actually acquired and reconstructed, or mixing up the qualifier for FDG with other, less common oncologic tracers.
Commonly Confused With
The main point of confusion is with Tomographic (Tomo) Nuclear Medicine Imaging of the respiratory system, since both produce three-dimensional cross-sectional images; the difference lies in detection physics, with PET requiring simultaneous 180-degree opposed photon capture from a positron-emitting isotope and SPECT relying on a rotating gamma camera detecting single photons from isotopes like technetium-99m. Coders should also avoid confusing a chest PET scan with a diagnostic chest CT performed for anatomic detail, since the CT portion of a combined study is coded separately under the Imaging section rather than folded into the nuclear medicine code.